In this Issue:
Renal impairment and outcomes with lenalidomide-dexamethasone for MM>
20 years of Fanconi anaemia data
Defibrotide for severe veno-occlusive disease and multiorgan failure
Gemtuzumab ozogamicin in older patients with newly diagnosed AML
High-dose daunorubicin induction in AML across cytogenetic/ molecular groups
BCR-ABL transcript type and TKI-treated chronic-phase CML outcomes
Outcomes in MCL after ibrutinib
Low-dose azacitidine for MDS in children and young adults
Anticoagulant therapy in three sepsis populations
Please login below to download this issue (PDF)